These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17895216)

  • 1. For how long is brain tissue salvageable? Thrombolysis-based evidence.
    Wechsler L; Lyden P
    J Stroke Cerebrovasc Dis; 2000 Nov; 9(6 Pt 2):21-3. PubMed ID: 17895216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alteplase treatment for acute stroke 2007: an effective therapeutic option at our disposal].
    Carneado-Ruiz J; Saver JL
    Rev Neurol; 2007 Jul 1-15; 45(1):42-52. PubMed ID: 17620265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolysis in acute ischemic stroke: controlled trials and clinical experience.
    Hacke W; Brott T; Caplan L; Meier D; Fieschi C; von Kummer R; Donnan G; Heiss WD; Wahlgren NG; Spranger M; Boysen G; Marler JR
    Neurology; 1999; 53(7 Suppl 4):S3-14. PubMed ID: 10532643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteplase: new indication. Inadequately assessed in ischaemic stroke.
    Prescrire Int; 2004 Aug; 13(72):127-31. PubMed ID: 15532135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making].
    Kakuda W; Abo M
    Brain Nerve; 2008 Oct; 60(10):1173-80. PubMed ID: 18975605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
    Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T
    Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How did the results of ECASS II influence clinical practice of treatment of acute stroke].
    Hacke W; Ringleb P; Stingele R
    Rev Neurol; 1999 Oct 1-15; 29(7):638-41. PubMed ID: 10599113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in drug treatment for acute ischemic stroke.
    Devuyst G; Bogousslavsky J
    Cerebrovasc Dis; 2001; 11 Suppl 1():71-9. PubMed ID: 11244203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombolytic therapy].
    Minematsu K
    Rinsho Shinkeigaku; 2006 Nov; 46(11):840-3. PubMed ID: 17432195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator use: evaluation and initial management of ischemic stroke from an Iowa hospital perspective.
    Albright KC; Schott TC; Jafari N; Wohlford-Wessels MP; Finnerty EP; Jacoby MR
    J Stroke Cerebrovasc Dis; 2005; 14(3):127-35. PubMed ID: 17904012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
    Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
    J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign angioedema after thrombolysis for acute stroke.
    Papamitsakis NI; Kuyl J; Lutsep HL; Clark WM
    J Stroke Cerebrovasc Dis; 2000; 9(2):79-81. PubMed ID: 17895201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous thrombolysis for acute ischemic stroke: the phase IV data.
    Tanne D; Demchuk AM; Kasner SE
    J Stroke Cerebrovasc Dis; 2002; 11(3-4):137-47. PubMed ID: 17903870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmoteplase.
    Paciaroni M; Medeiros E; Bogousslavsky J
    Expert Opin Biol Ther; 2009 Jun; 9(6):773-8. PubMed ID: 19456211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buying time for recanalization in acute stroke: arterial blood infusion beyond the occluding clot as a neuroprotective strategy.
    Ribó M; Molina C; Alvarez B; Dinia L; Alvarez-Sabin J; Matas M
    J Neuroimaging; 2009 Apr; 19(2):188-90. PubMed ID: 18800999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete].
    García-García J; Gracia-Gil J; Sopelana-Garay D; Ayo-Martín O; Vadillo-Bermejo A; Touza B; Peñalver-Pardines C; Zorita MD; Segura T
    Rev Neurol; 2008 Jan 1-15; 46(1):7-12. PubMed ID: 18214820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Past, present and future of alteplase for acute ischemic stroke.
    Quinn TJ; Dawson J; Lees KR
    Expert Rev Neurother; 2008 Feb; 8(2):181-92. PubMed ID: 18271705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.